SEC Form 4 · accession 0001493152-26-035310
Greenwich LifeSciences, Inc. · GLSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Snehal Patel
Officer — CEO and CFO · Director · 10% Owner
Period of report
Jul 28, 2026
Accepted (ET)
Jul 30, 2026 · 6:05 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001799788
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2026 | P | 1,500 | $13.59 | A | 5,610,702 | D | |
| Common Stock | Jul 29, 2026 | P | 700 | $13.10 | A | 5,611,402 | D |
Table II — derivative securities
No Table II lines on this filing.